TY - JOUR
T1 - Infection in systemic lupus erythematosus
AU - Petri, M.
PY - 1998
Y1 - 1998
N2 - The improved survival of SLE patients since the 1950s is the result of not only better treatment, but also supportive treatment of renal failure and the wealth of antibiotics now available. Ironically, the wider use of immunosuppressives, especially the alkylating drugs, and the longer survival of patients with renal insufficiency and renal failure have made the identification and appropriate treatment of infection in SLE an ongoing challenge.
AB - The improved survival of SLE patients since the 1950s is the result of not only better treatment, but also supportive treatment of renal failure and the wealth of antibiotics now available. Ironically, the wider use of immunosuppressives, especially the alkylating drugs, and the longer survival of patients with renal insufficiency and renal failure have made the identification and appropriate treatment of infection in SLE an ongoing challenge.
UR - http://www.scopus.com/inward/record.url?scp=0031803439&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031803439&partnerID=8YFLogxK
U2 - 10.1016/S0889-857X(05)70016-8
DO - 10.1016/S0889-857X(05)70016-8
M3 - Article
C2 - 9606766
AN - SCOPUS:0031803439
SN - 0889-857X
VL - 24
SP - 423
EP - 456
JO - Rheumatic Disease Clinics of North America
JF - Rheumatic Disease Clinics of North America
IS - 2
ER -